Investment firm and company builder Accelerator Life Science Partners has launched Proniras Corporation, a US-based developer of seizure disorder treatments, with an undisclosed amount of funding from investors including Alexandria Venture Investments, Johnson & Johnson Innovation – JJDC and WuXi AppTec Corporate Ventures, respective subsidiaries of real estate investment trust Alexandria Real Estate Equities and…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.